Interpace Biosciences Inc Valor contable por acción
¿Qué es el Valor contable por acción de Interpace Biosciences Inc?
El Valor contable por acción de Interpace Biosciences Inc es -21.82
¿Cuál es la definición de Valor contable por acción?
El valor en libros por acción es el activo de una empresa menos el pasivo dividido por el número de acciones en circulación.
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
Valor contable por acción de compañías en Sector Health Care en NASDAQ en comparadas con Interpace Biosciences Inc
¿Qué hace Interpace Biosciences Inc?
advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.
Empresas con valor contable por acción similar a Interpace Biosciences Inc
- Estre Ambiental tiene Valor contable por acción de -23.86
- MIC Electronics tiene Valor contable por acción de -23.21
- Tamilnadu Telecommunications tiene Valor contable por acción de -23.05
- Diamond Power Infrastructure tiene Valor contable por acción de -23.05
- Future Retail tiene Valor contable por acción de -22.51
- Just tiene Valor contable por acción de -22.31
- Interpace Biosciences Inc tiene Valor contable por acción de -21.82
- Nq Minerals Plc Spon Ads Each R tiene Valor contable por acción de -21.80
- Sotherly Hotels tiene Valor contable por acción de -21.63
- Sotherly Hotels Inc tiene Valor contable por acción de -21.39
- Sotherly Hotels Inc tiene Valor contable por acción de -21.35
- Premier Veterinary plc tiene Valor contable por acción de -21.30
- Jack In The Box tiene Valor contable por acción de -21.24